Literature DB >> 16179750

Reduction of diabetes-induced renal oxidative stress by a cantaloupe melon extract/gliadin biopolymers, oxykine, in mice.

Yuji Naito1, Satomi Akagiri, Kazuhiko Uchiyama, Satoshi Kokura, Norimasa Yoshida, Goji Hasegawa, Naoto Nakamura, Hiroshi Ichikawa, Shinya Toyokuni, Tetsuo Ijichi, Toshikazu Yoshikawa.   

Abstract

Oxidative stress is implicated as an important mechanism by which diabetes causes nephropathy. Oxykine is the cantaloupe melon extract rich in vegetal superoxide dismutase covered by polymeric films of wheat matrix gliadin. In this study, we examined whether chronic oral administration of oxykine could prevent the progression of diabetic nephropathy induced by oxidative stress using preclinical rodent model of type 2 diabetes. We used female db/db mice and their non-diabetic db/m littermates. The mice were divided into the following three groups: non-diabetic db/m; diabetic db/db, and diabetic db/db treated with oxykine. Blood glucose level, body weight, urinary albumin, and urinary 8-hydroxydeoxyguanosine (8-OHdG) were measured during the experiments. Histological and 8-OHdG immunohistochemical studies were preformed on 12 weeks from the beginning of treatment. After 12 weeks of treatment, the levels of blood glucose and the body weight were not significantly different between the oxykine-treated group and the non-treated db/db group, however both groups kept significantly high levels rather than db/m mice. The relative mesangial area calculated by mesangial area/total glomerular area ratio was significantly ameliorated in the oxykine treated group compared with non-treated db/db group. The increases in urinary albumin and 8-OHdG at 12 weeks of treatment were significantly inhibited by chronic treatment with oxykine. The 8-OHdG immunoreactive cells in the glomeruli of non-treated db/db mice were more numerous than that of oxykine-treated db/db mice. In this study, treatment of oxykine ameliorated the progression and acceleration of diabetic nephropathy for rodent model of type 2 diabetes. These results indicated that the oxykine reduced the diabetes-induced oxidative stress and renal mesangial cell injury. In conclusion, oxykine might be a novel approach for the prevention of diabetes nephropathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16179750     DOI: 10.1002/biof.5520230204

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  6 in total

1.  Effects of a cantaloupe melon extract/wheat gliadin biopolymer during aortic cross-clamping.

Authors:  Jochen Kick; Balázs Hauser; Hendrik Bracht; Maura Albicini; Sükrü Oter; Florian Simon; Ulrich Ehrmann; Catherine Garrel; Jörn Sträter; Uwe B Brückner; Xavier M Leverve; Hubert Schelzig; Günter Speit; Peter Radermacher; Claus-Martin Muth
Journal:  Intensive Care Med       Date:  2007-01-20       Impact factor: 17.440

2.  Prevention of inflammation-mediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available superoxide dismutase.

Authors:  F Okada; H Shionoya; M Kobayashi; T Kobayashi; H Tazawa; K Onuma; Y Iuchi; N Matsubara; T Ijichi; B Dugas; M Hosokawa
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

3.  Production of a Novel Superoxide Dismutase by Escherichia coli and Pichia pastoris and Analysis of the Thermal Stability of the Enzyme.

Authors:  Yang Zhao; Liang Zhao; Weiwei Zhang; Lei Rao; Yongtao Wang; Xiaojun Liao
Journal:  Front Nutr       Date:  2022-03-09

4.  Maintaining a physiological blood glucose level with 'glucolevel', a combination of four anti-diabetes plants used in the traditional arab herbal medicine.

Authors:  Omar Said; Stephen Fulder; Khaled Khalil; Hassan Azaizeh; Eli Kassis; Bashar Saad
Journal:  Evid Based Complement Alternat Med       Date:  2007-05-17       Impact factor: 2.629

5.  Effect of Cucumis sativus on Dysfunctional 3T3-L1 Adipocytes.

Authors:  Méndez-Martínez Marisol; Trejo-Moreno Celeste; Maldonado-Mejía Laura; Esquivel-Guadarrama Fernando; Pedraza-Chaverri José; Zamilpa Alejandro; Medina-Campos Omar; Alarcón-Aguilar Francisco; Almanza-Pérez Julio César; Contreras-Nuñez Erika; Santana-Calderón Angélica; Fragoso Gladis; Jiménez-Ferrer Enrique; Rosas Gabriela
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

Review 6.  Therapeutic potential of astaxanthin and superoxide dismutase in Alzheimer's disease.

Authors:  Vyshnavy Balendra; Sandeep Kumar Singh
Journal:  Open Biol       Date:  2021-06-30       Impact factor: 6.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.